EU/3/25/3136 (Active substance: Synthetic siRNA oligonucleotide against hepatitis B virus X gene transcripts, conjugated to N-acetylgalactosamine, sodium salt) – Orphan designation – Commission Decision (2025)7251 of Wed, 22 Oct 2025 – European Medicines Agency (EMA) procedure number: EMA/OD/0000258899